Ignite Creation Date:
2024-05-06 @ 10:27 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03264547
Status:
UNKNOWN
Last Update Posted:
2017-09-21
First Post:
2017-08-01
Brief Title:
A Study to Compare Eribulin Mesylate Pertuzumab Trastuzumab With Paclitaxel or Docetaxel Pertuzumab Trastuzumab
Sponsor:
Japan Breast Cancer Research Group
Organization:
Japan Breast Cancer Research Group
Organization Data
Organization:
Japan Breast Cancer Research Group
Class:
OTHER
Study ID:
JBCRG-M06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Japan Breast Cancer Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eisai Co Ltd | INDUSTRY |